These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 10768692)
1. Statistical analysis to settle ethical issues? Kraemer HC Arch Gen Psychiatry; 2000 Apr; 57(4):327-8. PubMed ID: 10768692 [No Abstract] [Full Text] [Related]
2. Placebo protects subjects from nonresponse: a paradox of power. Leon AC Arch Gen Psychiatry; 2000 Apr; 57(4):329-30. PubMed ID: 10768693 [No Abstract] [Full Text] [Related]
3. The placebo problem remains. Michels KB Arch Gen Psychiatry; 2000 Apr; 57(4):321-2. PubMed ID: 10768689 [No Abstract] [Full Text] [Related]
4. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Khan A; Warner HA; Brown WA Arch Gen Psychiatry; 2000 Apr; 57(4):311-7. PubMed ID: 10768687 [TBL] [Abstract][Full Text] [Related]
5. What conditions are necessary to assess antidepressant efficacy? Quitkin FM; Klein DF Arch Gen Psychiatry; 2000 Apr; 57(4):323-4. PubMed ID: 10768690 [No Abstract] [Full Text] [Related]
6. Are concerns about the ethics of placebos a stalking horse for other issues? Healy D Am J Bioeth; 2002; 2(2):17-9. PubMed ID: 12189063 [No Abstract] [Full Text] [Related]
8. Placebo controls: no news is good news. Leber P Arch Gen Psychiatry; 2000 Apr; 57(4):319-20. PubMed ID: 10768688 [No Abstract] [Full Text] [Related]
9. How can we know whether antidepressants increase suicide risk? Simon GE Am J Psychiatry; 2006 Nov; 163(11):1861-3. PubMed ID: 17074930 [No Abstract] [Full Text] [Related]
10. The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective. Laughren TP Eur Psychiatry; 2001 Nov; 16(7):418-23. PubMed ID: 11728855 [TBL] [Abstract][Full Text] [Related]
11. Use of placebos in clinical trials involving children and adolescents. Malone RP; Simpson GM Psychiatr Serv; 1998 Nov; 49(11):1413-4, 1417. PubMed ID: 9826239 [No Abstract] [Full Text] [Related]
12. Placebos and suicide. Harv Ment Health Lett; 2000 Aug; 17(2):6. PubMed ID: 10927652 [No Abstract] [Full Text] [Related]
13. Newer-Generation Antidepressants and Suicide Risk in Randomized Controlled Trials: A Re-Analysis of the FDA Database. Hengartner MP; Plöderl M Psychother Psychosom; 2019; 88(4):247-248. PubMed ID: 31234169 [No Abstract] [Full Text] [Related]
14. Type II error and antidepressants. Walker JB; Klein RM; Yee SL J Clin Psychiatry; 2001 May; 62(5):373-5. PubMed ID: 11411822 [No Abstract] [Full Text] [Related]
16. Placebo response and antidepressant clinical trial outcome. Khan A; Detke M; Khan SR; Mallinckrodt C J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731 [TBL] [Abstract][Full Text] [Related]
17. The value of data on suicidality by treatment arm. Smith EG Am J Psychiatry; 2010 Aug; 167(8):995; author reply 995-6. PubMed ID: 20693471 [No Abstract] [Full Text] [Related]
19. Qualms about balms: perspectives on antidepressants. Greenberg RP J Nerv Ment Dis; 2001 May; 189(5):296-8. PubMed ID: 11379972 [No Abstract] [Full Text] [Related]